36C25025Q0891.docx

DOCX document 16 KB Posted

Attached to
6505--PET MRI Radiopharmaceuticals - Notice of Intent to Sole Source
Solicitation number
36C25025Q0891
Issued by

About this file

This is a Special Notice of Intent to Sole Source for PET MRI Radiopharmaceuticals issued by the Department of Veterans Affairs (VA) Network Contracting Office 10. The VA intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co. for radiopharmaceutical supplies to be used at the John D. Dingell VA Medical Center in Detroit, MI. The contract will cover four specific radiopharmaceutical products: Cu-64 Dotatate (25 doses), F18 PSMA (70 doses), F18 Fluorodeoxyglucose (908 doses), and F18 Neuraceq (52 doses), with a performance period from October 1, 2025, through September 30, 2026.

The VA conducted a sources sought notice (36C25025Q0852) from August 18-22, 2025, which received responses from five contractors. After reviewing capabilities, the VA determined that Sofie Co. is the only vendor capable of providing all required radiopharmaceuticals. Interested parties may submit capability statements demonstrating competitive advantage to the Contracting Officer, Jeffrey Rozema, by 5:00 PM Eastern Time on September 2, 2025. The procurement falls under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) with a business size standard of 1,300 employees.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Special Notice Special Notice

SUBJECT*
PET MRI Radiopharmaceuticals - Notice of Intent to Sole Source

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
49037
SOLICITATION NUMBER*
36C25025Q0891
RESPONSE DATE/TIME/ZONE
09-02-2025 5:00 PM EASTERN TIME, NEW YORK, USA
ARCHIVE
60 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N
PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412
CONTRACTING OFFICE ADDRESS
Department of Veteran Affairs

Network Contracting Office 10 Battle Creek VA Medical Center 5500 Armstrong Rd.

Battle Creek MI 49037

POINT OF CONTACT*

Contracting Officer Jeffrey Rozema jeffrey.rozema@va.gov

ADDITIONAL INFORMATION

AGENCY’S URL
https://www.va.gov
URL DESCRIPTION
Agency Homepage
AGENCY CONTACT’S EMAIL ADDRESS
jeffrey.rozema@va.gov
EMAIL DESCRIPTION
Contracting Officer

DESCRIPTION

INTENT TO SOLE SOURCE

The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 – Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees.

The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2025, through September 30, 2026. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients.

Product Name
UoM
Est. Annual Quantity
Cu-64 Dotatate (Detectnet) 3-5 mCi
Dose
25
F18 PSMA (Pylarify) 8-10 mCi
Dose
70
F18 Fluorodeoxyglucose (FDG) 8-10 mCi
Dose
908
F18 Neuraceq 8-10 mCi
Dose
52

It is the Government’s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25025Q0852 was published on Contract Opportunities from August 18, 2025 through August 22, 2025. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine.

This notice satisfies the requirement at FAR 5.201(b)(1) to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Interested persons may identify their interests and capability to respond to this requirement no later than 5:00 PM Eastern Time, Tuesday, September 2, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.

Interest/capability statements shall be submitted to Jeffrey Rozema, Contracting Officer, via e-mail at jeffrey.rozema@va.gov. Telephone inquiries will not be accepted.

*= Required Field
Special Notice

Special Notice

File details come from the government source that posted it. Updated .